HUTCHMED CHINA-ADR (HCM) Forecast, Price Target & Analyst Ratings

NASDAQ:HCM • US44842L1035

Current stock price

14.56 USD
-0.31 (-2.08%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HUTCHMED CHINA-ADR (HCM).

Forecast Snapshot

Consensus Price Target

Price Target
$20.86
+ 43.27% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 5, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$20.86
Upside
+ 43.27%
From current price of $14.56 to mean target of $20.86, Based on 27 analyst forecasts
Low
$13.97
Median
$20.70
High
$28.17

Price Target Revisions

1 Month
25.37%
3 Months
35.41%

Price Target Summary

27 Wall Street analysts provided a forecast for the next 12 months for HCM. The average price target is 20.86 USD. This implies a price increase of 43.27% is expected in the next year compared to the current price of 14.56.
The average price target has been revised upward by 35.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HCM Current Analyst RatingHCM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

HCM Historical Analyst RatingsHCM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
HCM was analyzed by 27 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about HCM.
In the previous month the buy percentage consensus was at a similar level.
HCM was analyzed by 27 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-10B of A SecuritiesMaintains Buy -> Buy
2025-09-22Morgan StanleyDowngrade Equal-Weight -> Underweight
2025-07-22B of A SecuritiesMaintains Buy -> Buy
2024-08-01Goldman SachsMaintains Neutral -> Neutral
2023-11-24Deutsche BankUpgrade Hold -> Buy
2023-11-10Goldman SachsMaintains Neutral -> Neutral
2023-09-05Cantor FitzgeraldReiterate Overweight -> Overweight
2023-07-24Cantor FitzgeraldReiterate Overweight -> Overweight
2022-08-09Goldman SachsMaintains Neutral
2022-08-02Goldman SachsMaintains Neutral
2021-09-22Goldman SachsDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 5, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
HCM revenue by date.HCM revenue by date.
837.999M
96.52%		630.201M
-24.80%		548.512M
-12.96%		661.53M
20.60%		764.89M
15.62%		847.33M
10.78%		1.744B
105.82%		1.924B
10.32%
EBITDA
YoY % growth
HCM ebitda by date.HCM ebitda by date.
26.582M
106.66%		-31.364M
-217.99%		-25.852M
17.57%		28.019M
208.38%		63.523M
126.71%		77.046M
21.29%		N/AN/A
EBIT
YoY % growth
HCM ebit by date.HCM ebit by date.
18.375M
104.51%		-43.705M
-337.85%		-39.16M
10.40%		6.746M
117.23%		45.392M
572.87%		60.73M
33.79%		521.83M
759.26%		649.21M
24.41%
Operating Margin
HCM operating margin by date.HCM operating margin by date.
2.19%-6.94%-7.14%1.02%5.93%7.17%29.92%33.74%
EPS
YoY % growth
HCM eps by date.HCM eps by date.
N/A
103.51%		N/A
-536.91%		N/A
892.65%		0.34
-86.64%		0.57
64.73%		0.87
53.98%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HCM Yearly Revenue VS EstimatesHCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
HCM Yearly EPS VS EstimatesHCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-30.28%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
11.80%
Revenue Next 5 Year
25.98%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
41.81%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HUTCHMED CHINA-ADR / HCM Forecast FAQ

What do analysts expect the price target to be for HUTCHMED CHINA-ADR (HCM)?

27 analysts have analysed HCM and the average price target is 20.86 USD. This implies a price increase of 43.27% is expected in the next year compared to the current price of 14.56.

Can you provide the upcoming earnings date for HUTCHMED CHINA-ADR?

HUTCHMED CHINA-ADR (HCM) will report earnings on 2026-08-05.

Can you provide the expected long term growth rate for HUTCHMED CHINA-ADR stock?

The expected long term growth rate for HUTCHMED CHINA-ADR (HCM) is 11.8%.